DocumentOpenPublication

Add 6 Pharmacare Brand Alternative Emergency supply ↓

HealthRef: HP13-2025ARV

Official source

Source domain: health.gov.za

Collected on 14 September 2026

Always confirm details on the official source before acting.

What this means

This document is an addendum to a government contract for the supply of anti-retroviral medicines. It approves an emergency supply of 614,489 units of Luvigen tablets (an alternative brand to VULANTE) for use within six months. The approval is granted to Pharmacare Limited under Contract Number HP13-2025ARV.

What this document offers

Read out of this document by Govermate's AI, in its own words. Each one quotes the line it came from — confirm on the official source before acting.

emergency medical supply contractOpen

Emergency supply of Dolutegravir 50mg, Lamivudine 300mg, Tenofovir 300mg tablet (Luvigen) as alternative brand

The Department of Health has approved an emergency supply of 614,489 units of Luvigen tablets, which are an alternative brand to VULANTE TAB BOT 28 TND, for use in the national anti-retroviral programme.

Who it is for: Pharmacare Limited and other approved pharmaceutical suppliers
How to act on it: No action required by external parties; the approval is internal and directed to the supplier already named.
Closes: 17 February 2027

The document's recorded date is 17 August 2026. Confirm on the official source.

Facts

Reference

HP13-2025ARV

Key Takeaways

HP13-2025ARV
17/8/2026
17/2/2027
614489 units
DOLUTEGRAVIR 50mg, LAMIVUDINE 300mg, TENOFOVIR 300mg tablet
Luvigen
Pharmacare Limited
Pharmacare Limited
K JAMALOODIEN
Department of Health
Health Products Procurement Directorate

Dates

Closing Date (read from the document by Govermate)

17 February 2027